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Tbjective: Coronary artery bypass graft surgery carries increased risk for patients
equiring dialysis compared with other groups. Little data exist comparing
utcomes of on-pump and off-pump techniques in dialysis patients. This study
ompares outcomes of bypass grafting in dialysis patients with these two
echniques at a single institution and in the United States Renal Data System
USRDS) database.
ethods: From March 1997 to April 2004, 37 patients requiring dialysis underwent
ypass graft surgery at our institution. On-pump surgery was performed for 16
atients and off-pump surgery for 21. From January 1, 2001, to December 31, 2002,
total of 3922 patients in the USRDS underwent bypass graft surgery. On-pump
urgery was performed for 3382 and off-pump surgery for 540. Comparisons were
ade between patients undergoing on-pump and off-pump bypass surgery with
espect to demographics, risk factors, and outcomes. Univariate analysis, the
aplan-Meier method, and a multivariate Cox model were used.
esults: Institutional analysis revealed similar patient demographics, risk factors,
se of thoracic artery grafts, and number of distal anastomoses. Outcome analysis
as significant for less postoperative atrial fibrillation with the off-pump technique:
7.5% on-pump and 4.8% off-pump (P  .028). USRDS data revealed all-cause
urvivals at 1 and 18 months of 87.5% and 59.5% for on-pump versus 88.3% and
1.9% for off-pump procedures (P  .226). In a comorbidity-adjusted Cox model,
ff-pump bypass grafting was associated with a 16% reduction in all-cause mortality
P  .032).
onclusion: Off-pump bypass grafting is uncommon in patients in the United States
ho require dialysis. Off- pump bypass grafting provides a morbidity benefit and is
ssociated with a lower risk of death.
ardiac disease is the leading cause of death in patients requiring dialysis,
accounting for greater than 40% of mortality.1 Several studies have show
that dialysis patients have improved long-term outcomes when treated with
oronary artery bypass grafting (CABG) compared with percutaneous proce-
ures.2-5 Multiple studies evaluating on-pump CABG in dialysis patients 
hown short-term mortality rates from 7.8% to 20%, which are considerably higher
he Journal of Thoracic and Cardiovascular Surgery ● Volume 131, Number 6 1261
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1
A
CDhan typical reports of 2% to 3% in patients not receiving
ialysis.6-11 Recent trials have evaluated off-pump CAB
s a technique to decrease morbidity and mortality in high-
isk patient populations.12,13 Off-pump CABG in patien
equiring dialysis has been evaluated in several small ret-
ospective studies and has shown decreased blood loss,
eductions in ventilator and intensive care unit times, less
eed for postoperative dialysis, and lower costs.12-16 Our
ardiac surgical program is characterized by a low-volume,
igh-risk population. Approximately 11% of our CABG
atients have end-stage renal disease (ESRD) compared
ith an average of 1% in The Society of Thoracic Surgeons
ational database. In an attempt to optimize outcomes, we
ave adopted off-pump CABG as our procedure of choice
or appropriate candidates. In this article we report our
xperience with this approach and the nationwide results
rom the United States Renal Data System (USRDS) data-
ase for dialysis patients undergoing CABG.
ethods
rom May 1997 to April 2004, 37 patients requiring dialysis
nderwent primary CABG at Hennepin County Medical Center,
inneapolis, Minnesota. Of these patients, 16 (43.6%) were op-
rated on with an on-pump technique and 21 (56.4%), off-pump.
efore the year 2000, all procedures were performed on-pump.
eginning in 2000 an aggressive approach to off-pump surgery
as initiated. Since that time 21 of 24 CABG operations for
atients requiring dialysis have been performed with off-pump
echnique. Three have been performed on-pump for the following
ndications: a mycotic aneurysm of the circumflex artery at the site
f a percutaneously placed stent, a circumflex artery located deep
n the myocardium, and one procedure done by an visiting surgeon
ho does not perform off-pump CABG surgery. All operations
ere performed through a median sternotomy. Patients undergoing
ombined procedures or reoperations were not included. This
tudy was reviewed and approved by the Human Subject Research
ommittee of the Hennepin County Medical Center Institutional
eview Board.
perative Technique
On-pump CABG. Heparin was given to achieve an activated
lotting time of 480 seconds. Cardiopulmonary bypass (CPB) was
stablished between the ascending aorta and right atrium. A cor-
nary sinus catheter was placed for retrograde perfusion during
ardioplegia. Cold blood cardioplegia was accomplished with an-
Abbreviations and Acronyms
CABG  coronary artery bypass grafting
CPB  cardiopulmonary bypass
ESRD  end-stage renal disease
ICD  International Classification of Disease
USRDS United States Renal Data Systemegrade delivery through the aortic root and retrograde delivery S
262 The Journal of Thoracic and Cardiovascular Surgery ● Junhrough the coronary sinus. CPB was carried out under mild
ypothermia (32°C). Heparin was reversed with protamine at the
ompletion of the anastomoses.
Off-pump CABG. Heparin was given to achieve an activated
lotting time greater than 300 seconds. Deep pericardial stitches
ere placed to manipulate the heart and expose the coronary
rteries. An Octopus coronary stabilizer, (Medtronic, Inc, Minne-
polis, Minn) was used. Distal anastomoses were performed first.
roximal anastomoses were then completed with a side clamp
pplied the ascending aorta. Heparin was reversed with protamine
fter completion of the anastomoses.
Retrospective review of our institutional cardiac surgery data-
ase maintained since January 1997 was performed. These data are
rospectively collected in The Society of Thoracic Surgeons for-
at and submitted as part of the national database program.
Lumedex, Seattle, Wash) The database was reviewed for demo-
raphics, preoperative risk factors, intraoperative data, and post-
perative outcomes. Statistical analysis of categorical variables
as performed by the Pearson 2 test or the Fisher exact test.
ontinuous variables were analyzed with the 2-sample t test.
tatistical analysis was performed with SAS version 8 (SAS In-
titute, Inc, Cary, NC).
SRDS Data
ata were retrospectively collected from the USRDS, which con-
ains information on 1.5 million patients with ESRD. This database
ncludes all patients requiring dialysis in the United States.17 Most
ata sets used by USRDS are provided by the Centers for Medicare
nd Medicare Services. Administrative data come from Medicare
laims, parts A (hospitalization) and B (physician/provider). The
ccuracy of these data has been previously validated.18
The present study was a retrospective analysis of dialysis
atients undergoing CABG surgery after initiation of renal re-
lacement therapy. Eligible patients had received renal replace-
ent therapy for 90 days or more. Exclusion criteria included a
istory of CABG or valve surgery after initiation of dialysis or
oncomitant valve surgery during CABG.
Patients were identified from the USRDS by International
lassification of Disease codes (ICD-9-CM) for CABG surgery
code 36.1) between January 1, 2001, and December 31, 2002.
urgery performed without CPB was recognized by off-pump CPT
ode 00566. Patients receiving internal thoracic artery grafts
ere identified by ICD-9-CM codes 36.15 and 36.16. Data
valuated for patient characteristics and survival data were
btained from Medicare claims. Patient characteristics evaluated
ncluded age, gender, race, ESRD etiology, prior ESRD time,
omorbidities identified before hospitalization, and internal tho-
acic artery graft use.
Patients were followed up from the date of CABG surgery to
he earliest of death, transplant, loss to follow-up, or March 31,
003. Patients’ baseline characteristics with on-pump and off-
ump CABG surgery were compared by 2 square tests. Long-
erm survival was estimated by the Kaplan-Meier method, and
urvival of subgroups was compared by the log-rank test. The
ffect of off-pump CABG surgery on outcomes was estimated
y the Cox proportional hazards model, with adjustment for
atient characteristics. Statistical analysis was performed with
AS version 8.
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A
CDesults
eview of institutional results showed that patients un-
ergoing on-pump and off-pump CABG surgery were
imilar in terms of age, gender, race, and ESRD etiology
Table 1). Comordities evaluated included hypertensio
revious cerebrovascular accident, peripheral vascular
ABLE 1. Baseline patient characteristics in the cardiac s
On-pump (n  16
No. % (70
ge (y), mean (SD) 16 59 (10
ender
Male 9 56.3 (40
Female 7 43.7 (28
ace
White 11 68.6 (52
African American 1 6.2 (1.0
Other 4 25 (13
SRD etiology
Diabetes 11 68.6 (52
HTN 3 18.8 (8.5
Other 2 12.5 (4.3
omorbidity
PVD 6 37.5 (23
HTN 14 87.5 (72
CVA 1 6.2 (1.0
COPD 0 0
MI 12 75 (59
EF 40% 9 56.3 (40
Other cardiac 4 25.0 (13
TA graft 14 87.5 (72
istal anastomosis, mean (SD) 3.25 (1.0
HF, Congestive heart failure; CI, confidence interval; COPD, chronic o
ccident; EF, ejection fraction; ESRD, end-stage renal disease; HTN, hyper
ascular disease; SD, standard deviation. *Using a 2-sample t test for con
ariables.
ABLE 2. Complications and length of stay in the cardiac
On-pump (n 
N % (7
eoperative bleeding 0
erioperative MI 3 18.8 (8
nfected leg wound 2 12.5 (4
epsis 3 18.8 (8
VA 1 6.3 (1
rolonged mechanical ventilation 6 37.5 (2
neumonia 3 18.8 (8
ther GI complications 2 12.5 (4
trial fibrillation 6 37.5 (2
eath 2 12.5 (4
ospital LOS (d), mean (SD) 10.31 (6
I, Confidence interval; CVA, cerebrovascular accident; MI, myocardial infa
eviation. *Using 2-sample t test for continuous variable and the Fisher exact
The Journal of Thoracicisease, chronic obstructive pulmonary disease, previous
yocardial infarction, and ejection fraction of 40% or
ess (Table 1). Patients were similar with regard to 
omorbidities. An internal thoracic artery graft was used
n 14 of 16 (87.5%) on-pump operations and 20 of 21
95%) off-pump, P  .39. Mean number of distal anas-
cal program
Off-pump (n  21)
P value*No. % (70% CI)
21 62 (9.99) .430
.729
.1) 13 61.9 (48.2, 74.2)
.6) 8 38.1 (25.8, 51.8)
.231
.8) 9 42.9 (30.1, 56.5)
) 5 23.8 (13.7, 37.1)
.9) 7 33.3 (21.6, 47.0)
.865
.8) 16 76.2 (62.9, 86.3)
) 2 9.5 (3.3, 21.1)
) 3 14.3 (6.4, 26.6)
.6) 9 42.9 (30.1, 56.5) .742
.7) 21 100 (91.4, 100) .096
) 4 19.0 (10.0, 31.9) .259
1 4.8 (0.8, 15.2) .376
.8) 11 52.4 (39.0, 65.5) .16
.1) 6 28.6 (17.6, 42.1) .089
.9) 5 23.8 (13.7, 37.1) .933
.7) 20 95 (84.8, 99.2) .393
3.33 (0.73) .771
tive pulmonary disease; CI, confidence interval; CVA, cerebrovascular
n; ITA, internal thoracic artery; MI, myocardial infarction; PVD, peripheral
s variables and the Pearson’s 2 test or Fisher exact test for categorical
ical program
Off-pump (n  21)
P value*I) N % (70% CI)
0 0 NA
.1) 0 0 .072
.1) 3 14.3 (6.4, 26.6) .999
.1) 1 4.8 (0.8, 15.2) .296
.6) 1 4.8 (0.8, 15.2) .999
3.6) 4 19.0 (10.0, 31.9) .274
.1) 1 4.8 (0.8, 15.2) .296
.1) 0 0 .180
3.6) 1 4.8 (0.8, 15.2) .029
.1) 1 4.8 (0.8, 15.2) .568
10.23 (6.16) .972
; GI, gastrointestinal; LOS, length of stay; NA, not applicable; SD, standardurgi
)
% CI)
.6)
.4, 71
.9, 59
.7, 81
, 19.6
.2, 40
.7, 81
, 34.1
, 27.1
.4, 53
.9, 95
, 19.6
.2, 86
.4, 71
.2, 40
.9, 95
)
bstruc
tensio
tinuousurg
16)
0% C
0
.5, 34
.3, 27
.5, 34
.0, 19
3.4, 5
.5, 34
.3, 27
3.4, 5
.3, 27
.37)
rction
test for categorical variables.
and Cardiovascular Surgery ● Volume 131, Number 6 1263
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1
A
CDomoses was 3.25 in the on-pump group and 3.33 in the
ff-pump group, P  .77. Outcomes were similar in
erms of bleeding requiring reoperation, perioperative
yocardial infarction, leg infections, perioperative sep-
is, pneumonia, cerebrovascular accident, prolonged ven-
ilator support, gastrointestinal complications, mortality,
nd hospital length of stay (Table 2). Patients underg
ff-pump surgery had a lower incidence of new-onset
trial fibrillation, 1 of 21 (4.8%) versus 6 of 16 (37.5%),
ABLE 3. Baseline patient characteristics, USRDS data
All On-pump Off-pump
P value*
(n  3922)
100
(n  3382)
86.2
(n  540)
13.8
ge (y) .0001
45 6.0 6.1 5.4
45-64 42.6 43.8 34.8
65-74 35.0 34.7 37.2
75 16.4 15.4 22.6
ender .5598
Male 60.0 59.8 61.1
Female 40.0 40.2 38.9
ace .0713
White 65.5 64.8 69.6
African American 28.5 29.2 24.4
Other 6.0 6.0 5.9
rior ESRD time (y) .8151
1 23.7 23.5 25.2
1-2 21.2 21.2 21.1
2-5 37.1 37.1 36.7
5 18.0 18.2 17.0
SRD etiology .3079
Diabetes 56.5 56.8 54.8
HTN 24.4 24.5 23.7
Other 19.1 18.9 21.5
omorbidity
ASHD 53.8 54.0 52.6 .5363
Cancer 8.5 8.0 11.3 .0109
Cardiac (other) 31.4 31.1 33.7 .2220
CHF 32.2 31.9 34.1 .3096
COPD 15.6 15.3 17.4 .2070
CVA/TIA 12.9 12.2 16.7 .0043
Gallbladder 3.9 3.8 4.8 .2376
GI bleeding 10.8 10.5 12.8 .1181
Liver disease 1.6 1.7 0.9 .2031
PVD 27.0 26.5 30.0 .0910
TA graft
Yes 73.3 72.8 76.5 .0723
SHD, Atherosclerotic heart disease; CHF, congestive heart failure; COPD,
hronic obstructive pulmonary disease; CVA, cerebrovascular accident;
SRD, end-stage renal disease; GI, gastrointestinal; HTN, hypertension;
TA, internal thoracic artery; PVD, peripheral vascular disease; TIA, tran-
ient ischemic attack; USRDS, United States Renal Data System. All
umbers given in percentage. *Using the 2 test. .03. 0
264 The Journal of Thoracic and Cardiovascular Surgery ● JunSRDS
total of 3922 dialysis patients who underwent CABG sur-
ery were evaluated. Of these patients, 3382 (86%) had their
peration performed on-pump and 540 (14%) off-pump. The
ean follow-up time is 10.8 months (SD 7.9) for the on-pump
roup and 10.4 months (SD 7.4) for the off-pump group, P 
2598. Comparison of demographics revealed that patients
ndergoing on-pump CABG tended to be younger, with 49.9%
eing less than 65 years old versus 40.2% in the off-pump
roup, P .0001. The off-pump group also had more patients
ith a prior malignancy (11.3% vs 8.0%; P  .01) and a
igher incidence of prior cerebrovascular accident or transient
schemic attack (16.7% vs 12.2%; P  .004). Patients in both
roups were similar in terms of gender, race, duration of
SRD, ESRD etiology, and other comorbidities (Table 
nternal thoracic artery grafts were used in 72.8% of on-pump
ersus 76.5% of off-pump CABG operations, P  .072.
SRDS data revealed all-cause survivals at 1 and 18 months of
7.5% and 59.5% for on-pump versus 88.3% and 61.9% for
ff-pump operations, P  .226 (Figure 1). In-hospital death
ccurred in 12.0% of patients undergoing on-pump pro-
edures and 10.9% off-pump, P  .471. Patients in the
ff-pump CABG group were older and had a greater
umber of comorbidities. To adjust for baseline differ-
nces in demographics and comorbidities between pa-
ients in the off-pump and on-pump groups, a multivar-
ate Cox proportional hazards model was used. The
stimated hazard ratio using a Cox model for off-pump
ABG as a predictor of all-cause death was 0.84 (0.72,
igure 1. Kaplan-Meier survival estimates of time to all-cause
ortality. The numbers below the x-axis indicate the number of
vent-free patients under observation at 0, 6, 12, 18, and 24
onths. P  0.2263 for comparison of patients with to those
ithout CPB by log-rank test..99), P  .032 (Table 4). Other independent risk factors
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A
CDor all-cause death using this model included age greater
han 65 years, female gender, ESRD duration greater than
years, diabetes, hypertension, other cardiac disease,
hronic obstructive pulmonary disease, cerebrovascular
ccident/transient ischemic attack, liver disease, periph-
ral vascular disease, and not using an internal thoracic
rtery graft (Table 4).
iscussion
he merits of on-pump versus off-pump CABG surgery
ABLE 4. Results of Cox proportional hazards model of
ll-cause mortality in patients undergoing off-pump or on-
ump CABG, USRDS data
Hazard ratio (95% CI) P value
ff-pump CABG surgery 0.84 (0.72, 0.99) .0325
ge (y)
45 0.89 (0.68, 1.16) .387
65-74 1.39 (1.23, 1.58) .0001
75 1.87 (1.60, 2.18) .0001
ender
Female 1.19 (1.07, 1.33) .0017
ace
African American 0.99 (0.87, 1.12) .8457
Other 1.01 (0.80, 1.27) .9533
rior ESRD time (y)
1-2 0.95 (0.80, 1.13) .5395
2-5 1.30 (1.13, 1.51) .0004
5 1.41 (1.18, 1.69) .0001
SRD etiology
Diabetes 1.36 (1.17, 1.59) .0001
HTN 1.23 (1.04, 1.46) .0141
omorbidity
ASHD 1.01 (0.89, 1.14) .8657
Cancer 1.03 (0.86, 1.23) .764
Cardiac (other) 1.17 (1.04, 1.32) .0096
CHF 1.04 (0.92, 1.17) .5648
COPD 1.45 (1.27, 1.66) .0001
CVA/TIA 1.21 (1.05, 1.40) .0082
Gallbladder 1.26 (1.00, 1.59) .0522
GI bleeding 1.04 (0.89, 1.22) .6235
Liver disease 1.76 (1.24, 2.52) .0018
PVD 1.28 (1.14. 1.44) .0001
TA graft
Yes 0.86 (0.77, 0.97) .0133
SHD, Atherosclerotic heart disease; CABG, coronary artery bypass graft-
ng; CHF, congestive heart failure; CI, confidence interval; COPD, chronic
bstructive pulmonary disease; CVA, cerebrovascular accident; ESRD,
nd-stage renal failure; GI, gastrointestinal; HTN, hypertension; ITA, inter-
al thoracic artery; PVD, peripheral vascular disease; TIA, transient isch-
mic attack; USRDS, United States Renal Data System. The reference
roup has the following characteristics: CABG surgery performed with
ardiopulmonary bypass; age between 45 and 64 years; male gender; white
ace; prior ESRD duration less than 1 year; other ESRD etiology; no
omorbid conditions; no ITA graft.ave been a source of considerable debate in recent years. a
The Journal of Thoracicotential benefits of off-pump surgery include less postop-
rative cognitive impairment,19 a lower incidence of ren
ailure,20 less blood loss, less prolonged mechanical ve-
ation, shorter intensive care unit and hospital stays, and
ower mortality in high-risk groups.21-23
One concern regarding off-pump surgery has been
dequacy of revascularization owing to the difficulty of
xposing the circumflex artery and its branches with this
echnique.24 A fairly consistent pattern of fewer di
nastomoses being performed with the off-pump technique
s present in the existing literature. This is somewhat con-
erning given the 26% reduction in mortality that has been
hown with complete versus incomplete revascularization
fter CABG surgery.25 Advances in technology for cardi
tabilization and increased experience with positioning have
llowed surgeons to overcome some of these challenges. A
ecent randomized study including 200 patients showed
imilar rates of complete revascularization for CABG with
n-pump and off-pump techniques when performed by an
xperienced surgeon.21 In our experience, we performed
imilar number of anastomoses in cases with and without
he pump.
Several studies have addressed the question of whether
ertain high-risk populations would benefit more from off-
ump CABG surgery. Theoretically, this idea is appealing
n dialysis patients, in whom smaller volume shifts associ-
ted with reduced production of inflammatory mediators
ay be particularly beneficial. A number of small retro-
pective series have recently addressed this possibility.
apadimitriou and associates14 reviewed 34 dialysis pa-
ients undergoing CABG, 15 of whom had off-pump pro-
edures. They showed less blood loss, lower catabolic rates,
nd less frequent postoperative dialysis in off-pump pa-
ients. Tashiro and colleagues15 performed 26 CABG ope-
tions on dialysis patients, with 15 completed off-pump.
heir results included decreased ventilator time, shorter
ntensive care unit time, and lower cost. A series of 40
emodialysis patients operated on by Hirose and cowork-
rs16 included 16 patients having off-pump operations. T
ound less blood loss, a lower overall complication rate,
horter intubation times, shorter intensive care unit stays,
nd less frequent postoperative dialysis in patients under-
oing off-pump surgery. The primary benefit of off-pump
ABG in our institutional series of 21 off-pump procedures
as a lower incidence of postoperative atrial fibrillation
hen compared with 16 patients undergoing on-pump
ABG. Although all of these small series showed signifi-
ant decreases in morbidity with the off-pump technique,
one was able to independently show a survival benefit.
Using USRDS data allowed us to evaluate outcomes for
large volume of dialysis patients from many different
nstitutions who received CABG. When a Cox model was
pplied to adjust for independent risk factors, off-pump
and Cardiovascular Surgery ● Volume 131, Number 6 1265
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1
A
CDABG was associated with a 16% reduction in risk of
ll-cause death.
The primary limitations of our study include its retro-
pective nature, a short follow-up time, and the possible
mpact of selection bias for choice of procedure.
Although the majority of CABG operations for dialysis
atients are performed with CPB, USRDS data would sug-
est that a survival benefit exists for patients undergoing
ff-pump CABG. In addition multiple institutional reports
ncluding our own data indicate that the off-pump technique
rovides a significant reduction in the morbidity associated
ith CABG.
The USRDS data also suggest that surgeons may already
e risk stratifying high-risk patients to off-pump CABG. In
ddition, the data suggest that the internal thoracic artery
ay be underused in these patients. All of these areas show
oom for improving the long-term outcome of dialysis pa-
ients undergoing CABG.26
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